Improved clinical outcomes and physical activity in patients with rheumatoid arthritis treated with originator adalimumab in routine clinical practice
Journal Title: International Journal of Clinical Rheumatology - Year 2018, Vol 13, Issue 6
Abstract
Background/Objective: We aimed at evaluating changes in habitual physical activity, disease activity and physical function following treatment with originator adalimumab (ADAORIG) in patients with Rheumatoid Arthritis (RA) in routine clinical practice. Methods: This observational study followed RA patients for 12 months, using the DAS28, HAQ-DI and Short QUestionnaire to ASsess Health-enhancing physical activity (SQUASH) instruments to measure disease activity, physical function and habitual physical activity, respectively. Associations of SQUASH scores with DAS28, HAQ-DI and socio-demographic factors were evaluated by correlation coefficients and multivariable regression analyses. Results: From baseline to final visit, the mean SQUASH total score increased from 4772 ± 4132 to 6104 ± 4921 (n=460), representing a 28% improvement in overall physical activity. Largest improvements were observed in the domains of leisure time and sport (42%), and activities at work and school (35%). Mean DAS28 and HAQ-DI scores decreased by 2.8 and 0.7 points, respectively, but a sizeable negative correlation was found only between baseline SQUASH total score and HAQ-DI score (–0.30; p<0.0001). Advancing age was negatively associated with the final SQUASH total score (effect estimate of –46.2, p<0.05). Conclusion: Improvements in habitual physical activity, disease activity, and physical function were observed in RA patients after 12 months of ADAORIG therapy.
Authors and Affiliations
Dmitry Karateev, Bernadette Rojkovich, Maja Hojnik, Orsolya Nagy, Catalin Codreanu
Keywords
Related Articles
- EP ID EP604801
- DOI -
- Views 62
- Downloads 0
Risk of upper gastrointestinal adverse events in Malaysian rheumatic patients on long-term non-steroidal antiinflammatory drugs
Background: Non-steroidal anti-inflammatory drug (NSAID)-induced upper gastrointestinal (GI) adverse events are well-described in the Western population but data is lacking in Asian patients. This study aims to describe...
Rituximab can induce remission in a patient with rheumatoid arthritis and Ankylosing spondylitis
The efficacy of Rituximab (RTX) has been examined in Ankylosing Spondylitis (AS) and Rheumatoid Arthritis (RA) before. Here, we have reported the case of a patient with RA and AS showing good clinical improvement with RT...
Hyperuricemia as an independent predictor and prognostic factor in the development of lupus nephritis
Background: Lupus nephritis (LN) can increase morbidity and mortality risk in systemic lupus erythematosus (SLE) and 25% of the patients with LN will advance to end-stage renal disease. Objective: To evaluate if hyperuri...
Sickle cell trait in orthopaedic surgery: A real issue or just a bogeyman
Sickle cell disease is a hereditary blood disease characterized by the production of abnormal haemoglobin. HbS precipitates in the red cells under specific circumstances. The sickle cell trait (SCT), long considered an a...
Predictors of quality of life improvement following peer mentoring in AfricanAmerican women with systemic lupus erythematosus (sle)
Background: Systemic lupus erythematosus is a complex autoimmune disorder with heterogeneous presentation. Behavioral interventions have had mixed effects among this population, particularly among African American women,...